ÖZTÜRK, H. F. Et Al. 2023. From organ at risk to target organ: Dosimetric comparison of myocardial stereotactic ablative body radiotherapy between helical tomotherapy and volumetric arc therapy for refractory ventricular tachycardia. Medical Dosimetry , vol.48, no.4 , 293-298.

ÖZTÜRK, H. F., Arslan, S. A., Gani, Z., ARAS, D., & TEZCAN, Y., (2023). From organ at risk to target organ: Dosimetric comparison of myocardial stereotactic ablative body radiotherapy between helical tomotherapy and volumetric arc therapy for refractory ventricular tachycardia. Medical Dosimetry , vol.48, no.4, 293-298.

ÖZTÜRK, HÜSEYİN Et Al. "From organ at risk to target organ: Dosimetric comparison of myocardial stereotactic ablative body radiotherapy between helical tomotherapy and volumetric arc therapy for refractory ventricular tachycardia," Medical Dosimetry , vol.48, no.4, 293-298, 2023

ÖZTÜRK, HÜSEYİN F. Et Al. "From organ at risk to target organ: Dosimetric comparison of myocardial stereotactic ablative body radiotherapy between helical tomotherapy and volumetric arc therapy for refractory ventricular tachycardia." Medical Dosimetry , vol.48, no.4, pp.293-298, 2023

ÖZTÜRK, H. F. Et Al. (2023) . "From organ at risk to target organ: Dosimetric comparison of myocardial stereotactic ablative body radiotherapy between helical tomotherapy and volumetric arc therapy for refractory ventricular tachycardia." Medical Dosimetry , vol.48, no.4, pp.293-298.

@article{article, author={HÜSEYİN FURKAN ÖZTÜRK Et Al. }, title={From organ at risk to target organ: Dosimetric comparison of myocardial stereotactic ablative body radiotherapy between helical tomotherapy and volumetric arc therapy for refractory ventricular tachycardia}, journal={Medical Dosimetry}, year=2023, pages={293-298} }